Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001179110-09-007916

Options or other derivatives

  • CEO acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
LEWIS JONATHAN CEO 2009-05-13 Grant or award · Stock Option (right to buy) +100,000 100,000 D
Loading xslF345X03/edgar.xml…